Insmed | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Cytokinetics USD -266413000 131.04M 2025-03
DBV Technologies USD 27.4M 26.63M 2024-12
Dynavax Technologies USD 530.94M 65.86M 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Insmed USD 99.16M 186.22M 2025-03
Novartis USD 44.05B 729M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Insmed Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.